The emergence of somatostatin antagonist-based theranostics: Paving the road toward another success?

Alessio Imperiale,Abhishek Jha,Leah Meuter,Guillaume P Nicolas,David Taïeb,Karel Pacak

Journal of Nuclear Medicine（2023）

引用 1|浏览5

暂无评分

摘要

The value of in vivo peptide receptor targeting for imaging and treating oncologic patients is well accepted and implemented in clinical practice. A prime example is somatostatin receptor (SSTR)–targeted peptide receptor radionuclide therapy (PRRT), which relies on an image-and-treat approach (

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要